Skip to main content
OpenTrials
Completed

NCT Number: NCT07505563

MiniFlo for Advanced Dupuytren's Disease

The aim of this study is to investigate the potential use of the MiniFlo (CitiEffe) progressive distraction external fixator in the treatment of advanced Dupuytren's disease.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dupuytren's Disease Connective Tissue Diseases Contracture Dupuytren Contracture Fibroma Muscular Diseases Musculoskeletal Diseases Neoplasms Neoplasms by Histologic Type Neoplasms, Connective Tissue Neoplasms, Connective and Soft Tissue Neoplasms, Fibrous Tissue Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Hospital of Verona

Verona, VERONA, 37126, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Dupuytren's disease
  • Age ≥ 18 years
  • Informed consent

Exclusion criteria

  • Age < 18 years
  • Pregnancy
  • Withdrawal of informed consent

Treatment and study plan

MiniFlo

Device

MiniFlo distraction for the restoration of finger extension

Primary outcomes

  1. Extension deficit angle (degree)

    Time frame: 12 months

    Evaluation of extension deficit angle of fingers affected before and after the treatment. Min 0° (no deficit), Max 180° (high stage disease)

Secondary outcomes

  1. Collagenase adverse effects

    Time frame: 12 months

    Assessment of potential adverse effects related to the use of collagenase

  2. NRS scale

    Time frame: 12 months

    Evaluation of pain before and after the treatment. Min 0 (no pain), Max 10 (maximum pain)

Sponsors and collaborators

Lead sponsor

Azienda Ospedaliera Universitaria Integrata Verona

Other

Registry information

Official study title

Treatment of Stage III-IV Dupuytren's Disease With the MiniFlo External Fixator

Important dates

Study start
2014
Primary completion
2015
Study completion
2016
First posted
Apr 1, 2026
Registry last updated
Apr 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.